Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00278421
Recruitment Status : Completed
First Posted : January 18, 2006
Last Update Posted : October 26, 2016
Information provided by (Responsible Party):
German High-Grade Non-Hodgkin's Lymphoma Study Group

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2016
  Actual Study Completion Date : October 2016